USPTO's Proposed Rules on Claims and Continuations are Invalid [Apr. 2008] By Patrick Avakian A collective sigh was heard throughout the patent community, as news of the U.S. District Court's decision to reject the proposed U.S. Patent and Trademark Office (USPTO) rules ("Final Rules") was handed down yesterday. Originally set to be effective on Nov. 1, 2007, the Final Rules: (1) restricted the number of claims that can be included in a patent application, and in each family of applications associated with a particular invention, unless an examination support document (ESD) is filed; (2) reduced the number of continuation applications and requests for continued examination (RCE) that may be filed without a petition and showing; (3) required that patent applicants provide the USPTO with a report, for each pending application, of all applications and issued patents that share common inventorship, ownership, and a similar filing or priority date with the pending application; and (4) created a presumption that a family of applications with “patentably indistinct” claims exists if there is overlapping disclosure and a common filing/priority date, but permitted the applicant only a limited time to rebut the presumption if the allegedly “indistinct” claims are, in fact, “patentably distinct.” Ultimately, the U.S. District Court for the Eastern District of Virginia found the Final Rules to be substantive in nature and to exceed the scope of the USPTO's rulemaking authority under 35 U.S.C. §2(b)(2). The court further stated that its reading of §2(b)(2) was supported by the fact that, since 2005, Congress has debated and considered whether it should grant the USPTO substantive rulemaking authority but has declined to do so. The USPTO, which had argued that the changes were only procedural, said in a prepared statement that it did not agree with the court and is considering an appeal.

read bulletin

Corporate Finance
eHealth/HIPAA
Employment
Health Care
Health Information Technology
Tax-Exempt Organizations

Hot News in Life Sciences
Want to know what's hot in the life sciences industry? Check out our weekly news summary.

Laws are constantly changing. Fortunately, our lawyers are watching the legal developments that can affect your business. We regularly publish articles, advisory bulletins, and guides on legal developments that are of interest to you. Our publications are available free of charge by email and are posted on our website.

To sign up for our Advisory Bulletin email service, click here.

Highlights from week ending 11/7/07
Highlights from week ending 10/24/07
Highlights from week ending 10/10/07
Highlights from week ending 10/3/07
Highlights from week ending 9/26/07
Highlights from week ending 9/19/07
Highlights from week ending 9/12/07
Highlights from week ending 8/29/07
Highlights from week ending 8/22/07
Highlights from week ending 8/15/07
Highlights from week ending 8/1/07
Highlights from week ending 7/25/07
Highlights from week ending 7/18/07
Highlights from week ending 7/11/07
Highlights from week ending 7/4/07
Highlights from week ending 6/27/07
Highlights from week ending 6/20/07
Highlights from week ending 6/13/07
Highlights from week ending 6/06/07
Highlights from week ending 5/23/07
Highlights from week ending 5/16/07
Highlights from week ending 5/9/07
Highlights from week ending 5/2/07

click here for previous highlights

Expert Declarations Merit Special Consideration In Patent Prosecution Says Federal Circuit
[Sept. 2007] read bulletin

Supreme Court Criticizes Rigid Application of Obviousness Test [May 2007] read bulletin

Patent Reform Nearing Reality in 2007 [April 2007] read bulletin

Patent Licensees May Challenge Licensor Patents [Jan. 2007] read bulletin

U.S. Patents on Medical Diagnostics: Valid…For Now [June 2006] read bulletin

U.S. Patents on Biotechnical Subject Matter: Challenges of the Written Description Requirement [June 2006] read bulletin

Intellectual Property Protection at Trade Shows, Conferences and Symposia [Feb. 2006] read bulletin

Office of Inspector General Identifies Compliance Risk Areas for Researchers with Federal Funding [Dec. 2005] read bulletin

National Clinical Trials Database Legislation Introduced; Registration Already a Requirement for Some Medical Journals [Sept. 2005] read bulletin

U.S. Patent Office Announces Pilot Program for Pre-Appeal Brief Conferences [Aug. 2005]
read bulletin

New CREATE Act Affects Inventions and Patent Applications Arising from Research Collaborations
[Feb. 2005] read bulletin

Important Patent-Related News: Consolidated Appropriations Act, 2005 Took Effect on Dec. 8, 2004
Fees Increased for all Patent Applications Filed and Prosecuted in the U.S. [Dec. 2004] read bulletin

NIH Grants May Now Cover Patent and Licensing Costs [Dec. 2004] read bulletin

Is Your Life Sciences Company Ready for Financing? [March 2003] read bulletin